Common side effects include nausea, vomiting, constipation, and digestive discomfort
Many patients report considerably diminished appetite, satisfaction after smaller meals, reduced cravings for high-calorie food items, increased energy for physical activity, and enhancement of blood pressure, cholesterol, and blood sugar levels
Finally, treatment pauses of no fixed length are allowed to improve tolerability in the event of persistent GI-related adverse events
Everyone in the study was also offered cognitive behavioral therapy for alcohol use disorder
As a GLP-1 receptor agonist, it helps curb appetite and support sustainable weight reductiondelivering impressive results for many patients
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, particularly when initiating treatment or increasing the dose